Pedro Berzosa1, Vicenta González2, Laura Taravillo2, Alfredo Mayor3, María Romay-Barja2, Luz García2, Policarpo Ncogo4,5, Matilde Riloha4,5, Agustín Benito2. 1. Malaria Laboratory, National Centre of Tropical Medicine, Institute of Health Carlos III, Madrid, Spain. pberzosa@isciii.es. 2. Malaria Laboratory, National Centre of Tropical Medicine, Institute of Health Carlos III, Madrid, Spain. 3. ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain. 4. Global Health Programme, Malabo, Equatorial Guinea. 5. Malaria Programme, Ministry of Health and Social Welfare of Equatorial Guinea, Malabo, Equatorial Guinea.
Abstract
BACKGROUND: The World Health Organization (WHO) recommends rapid diagnostic tests (RDTs) as a good alternative malaria-diagnosis method in remote parts of sub-Saharan Africa. The majority of commercial RDTs currently available detect the Plasmodium falciparum protein histidine-rich protein 2 (PfHRP2). There have also been recent reports of pfhrp2 gene deletions being found in parasites collected from several African countries. The WHO has concluded that lacking the pfhrp2 gene must be monitored in Africa. The purpose of the study was to analyse why the samples that were positive by PCR were negative by RDTs and, therefore, to determine whether there have been deletions in the pfhrp2 and/or pfhrp3 genes. METHODS: Malaria NM-PCR was carried out on all the samples collected in the field. A group of 128 samples was positive by PCR but negative by RDT; these samples were classified as RDT false-negatives. PCR was carried out for exon2 of pfhrp2 and pfhrp3 genes to detect the presence or absence of these two genes. Frequencies with 95% confidence intervals (CIs) were used for prevalence estimates. Associations were assessed by the Chi square test or Fisher´s exact test. The level of significance was set at p ≤ 0.05. Statistical analyses were performed using the software package SPSSv.15.0. RESULTS: After PCR, 81 samples were identified (4.7%, 95% CI 3.8-5.8) which had deletion in both genes, pfhrp2 and pfhrp3. Overall, however, 11 samples (0.6%, 95% CI 0.36-1.14) had deletion only in pfhrp2 but not in pfhrp3, and 15 (0.9%, 95% CI 0.6-1.5) presented with deletion only in pfhrp3 but not in pfhrp2. Considering the pfhrp2 gene separately, within the total of 1724 samples, 92 (5.3%, 95% CI 4.37-6.5) had evidence of deletion. CONCLUSION: The present study provides the first evidence of deletion in the pfhrp2 and pfhrp3 genes in P. falciparum isolates from Equatorial Guinea. However, larger studies across different regions within the country and across different seasonal profiles are needed to determine the full extent of pfhrp2 and pfhrp3 deletion. It is strongly recommended to implement an active surveillance programme in order to detect any increases in pfhrp2 and pfhrp3 deletion frequencies.
BACKGROUND: The World Health Organization (WHO) recommends rapid diagnostic tests (RDTs) as a good alternative malaria-diagnosis method in remote parts of sub-Saharan Africa. The majority of commercial RDTs currently available detect the Plasmodium falciparum protein histidine-rich protein 2 (PfHRP2). There have also been recent reports of pfhrp2 gene deletions being found in parasites collected from several African countries. The WHO has concluded that lacking the pfhrp2 gene must be monitored in Africa. The purpose of the study was to analyse why the samples that were positive by PCR were negative by RDTs and, therefore, to determine whether there have been deletions in the pfhrp2 and/or pfhrp3 genes. METHODS:Malaria NM-PCR was carried out on all the samples collected in the field. A group of 128 samples was positive by PCR but negative by RDT; these samples were classified as RDT false-negatives. PCR was carried out for exon2 of pfhrp2 and pfhrp3 genes to detect the presence or absence of these two genes. Frequencies with 95% confidence intervals (CIs) were used for prevalence estimates. Associations were assessed by the Chi square test or Fisher´s exact test. The level of significance was set at p ≤ 0.05. Statistical analyses were performed using the software package SPSSv.15.0. RESULTS: After PCR, 81 samples were identified (4.7%, 95% CI 3.8-5.8) which had deletion in both genes, pfhrp2 and pfhrp3. Overall, however, 11 samples (0.6%, 95% CI 0.36-1.14) had deletion only in pfhrp2 but not in pfhrp3, and 15 (0.9%, 95% CI 0.6-1.5) presented with deletion only in pfhrp3 but not in pfhrp2. Considering the pfhrp2 gene separately, within the total of 1724 samples, 92 (5.3%, 95% CI 4.37-6.5) had evidence of deletion. CONCLUSION: The present study provides the first evidence of deletion in the pfhrp2 and pfhrp3 genes in P. falciparum isolates from Equatorial Guinea. However, larger studies across different regions within the country and across different seasonal profiles are needed to determine the full extent of pfhrp2 and pfhrp3 deletion. It is strongly recommended to implement an active surveillance programme in order to detect any increases in pfhrp2 and pfhrp3 deletion frequencies.
Authors: Dorcas G Bredu; George K Ahadzi; Donu Dickson; Nana Y Peprah; Alexander Asamoah; George A Asumah; Benjamin Abuaku; Kwame K Asare; Dorcas Obiri-Yeboah; Colby T Ford; Eugenia Lo; Keziah L Malm; Linda E Amoah Journal: Am J Trop Med Hyg Date: 2022-05-02 Impact factor: 3.707
Authors: Dianna E B Hergott; Jennifer E Balkus; Guillermo A García; Kurtis R Cruz; Annette M Seilie; Haley Masters; Akum A Aveika; Marcos Mbuilto Iyanga; Jeremias Nzamio Mba Eyono; Brandon L Guthrie; Sean C Murphy Journal: Malar J Date: 2021-07-12 Impact factor: 2.979
Authors: Thomas L Richie; Claudia A Daubenberger; Maxmillian Mpina; Thomas C Stabler; Tobias Schindler; Jose Raso; Anna Deal; Ludmila Acuche Pupu; Elizabeth Nyakarungu; Maria Del Carmen Ovono Davis; Vicente Urbano; Ali Mtoro; Ali Hamad; Maria Silvia A Lopez; Beltran Pasialo; Marta Alene Owono Eyang; Matilde Riloha Rivas; Carlos Cortes Falla; Guillermo A García; Juan Carlos Momo; Raul Chuquiyauri; Elizabeth Saverino; L W Preston Church; B Kim Lee Sim; Bonifacio Manguire; Marcel Tanner; Carl Maas; Salim Abdulla; Peter F Billingsley; Stephen L Hoffman; Said Jongo Journal: Malar J Date: 2022-03-24 Impact factor: 2.979